Johnson & Johnson: Auris Health Announces Late-Breaking Results From First-in-Human Study of Monarch Platform
October 23, 2019
October 23, 2019
NEW ORLEANS, Louisiana, Oct. 23 -- Johnson & Johnson issued the following news release:
* * *
- Data Presented at CHEST 2019 Demonstrates Efficacy of Monarch to Successfully Reach Nodules and Biopsy Tissue
* * *
Auris Health, Inc. ("Auris Health"), part of Johnson & Johnson Medical Devices Companies,* today announced results from a study demonstrating the safety and feasibility of the Monarch Platform, a first-of-its-kind robo . . .
* * *
- Data Presented at CHEST 2019 Demonstrates Efficacy of Monarch to Successfully Reach Nodules and Biopsy Tissue
* * *
Auris Health, Inc. ("Auris Health"), part of Johnson & Johnson Medical Devices Companies,* today announced results from a study demonstrating the safety and feasibility of the Monarch Platform, a first-of-its-kind robo . . .